![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Pronóstico del mercado de diagnóstico de cáncer de cerebro de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por tipo de diagnóstico (prueba de imágenes, punción lumbar, biopsia, pruebas moleculares y otros); Tipo de cáncer (neuroma acústico, astrocitoma, craneofaringiomas, ganglioneuromas, glioblastoma multiforme, meningiomas, ependimomas y otros); Usuario final (hospitales, clínicas especializadas, centros de cirugía ambulatoria y otros)
Introducción al mercado
Los cánceres de cerebro se producen debido al crecimiento extracelular de las células del cerebro que causan los tumores. El tumor incluye tumores cerebrales primarios y tumores cerebrales secundarios. Los tumores cerebrales primarios se forman en el cerebro y no se diseminan a otras partes del cuerpo, mientras que los tumores secundarios, también conocidos como metástasis, son aquellos cánceres que comenzaron en otra parte del cuerpo. Los tumores cerebrales se clasifican en 40 tipos principales que a su vez se clasifican en dos grupos principales: benignos, es decir, de crecimiento lento y que tienen menos posibilidades de propagarse, y malignos, es decir, cancerosos y con mayor probabilidad de propagarse.
< p>Por lo tanto, se espera que el aumento en la prevalencia del cáncer de cerebro cree una demanda significativa de diagnóstico de cáncer de cerebro en los próximos años, lo que se prevé que impulse aún más el mercado de diagnóstico de cáncer de cerebro.El brote ha afectado gravemente afectó la industria del turismo médico en Asia Pacífico e impuso interrupciones en la cadena de suministro; Además, los países de bajos ingresos enfrentan desafíos adicionales debido a la escasez de infraestructura de atención médica, las restricciones impuestas por los hospitales a los proveedores, la disminución de la demanda de dispositivos de diagnóstico del cáncer cerebral y otros. Se han adoptado medidas restrictivas en Corea del Sur, Malasia, Singapur, Filipinas e India para prevenir la transmisión de la enfermedad. Se prevé que estas medidas restrictivas afectarán la cadena de suministro y la disponibilidad de dispositivos médicos en estos países. Ha afectado los ingresos disponibles y también ha provocado desempleo. Además, las estrategias comerciales como adquisiciones, fusiones y asociaciones se ven afectadas negativamente por la imposición de un bloqueo total. Se prevé que tales obstrucciones en las actividades comerciales obstaculicen la adopción de diversos sistemas de atención médica tecnológicamente avanzados, incluido el diagnóstico de cáncer cerebral.
Descripción general y dinámica del mercado
Se espera que el mercado de diagnóstico de cáncer de cerebro en Asia Pacífico crezca de 178,6 millones de dólares en 2021 a 2021. 551,4 millones para 2028; se estima que crecerá a una tasa compuesta anual del 17,5% de 2021 a 2028. El término \"tumor cerebral primario\" se refiere a un tumor que comienza en el cerebro. El cáncer de cerebro y del sistema nervioso es la décima causa de mortalidad en hombres y mujeres. A lo largo de la vida de una persona, las posibilidades de tener este tipo de tumor son inferiores al 1%. La mayoría de las neoplasias malignas primarias del sistema nervioso central (SNC) son tumores cerebrales, que representan del 85% al 90% de todos los casos. Los tumores cerebrales pueden ser fatales, tener un impacto severo en la calidad de vida y, en última instancia, transformar la vida del paciente y su familia. Además, la detección temprana de tumores suele ofrecer más opciones de tratamiento. La tecnología de imágenes avanzada puede identificar la ubicación de los tumores cerebrales. Las herramientas de diagnóstico incluyen imágenes por resonancia magnética (MRI) y tomografía computarizada (CT o CAT). La resonancia magnética intraoperatoria también se puede utilizar para guiar la biopsia de tejido y la resección del tumor durante la cirugía. La espectroscopia de resonancia magnética (MRS) se utiliza para examinar las características químicas de los tumores. Por tanto, el aumento de la prevalencia del cáncer de cerebro exige en gran medida herramientas de diagnóstico del cáncer de cerebro.
Segmentos clave del mercado
En términos de tipo de diagnóstico, el segmento de pruebas de imágenes representó la mayor participación del mercado de diagnóstico de cáncer cerebral de Asia Pacífico en 2020. En términos de tipo de cáncer, el segmento de glioblastoma multiforme representó la mayor participación del mercado de diagnóstico de cáncer cerebral de Asia Pacífico en 2020. En términos de usuario final, el segmento de hospitales representó la mayor parte del mercado de diagnóstico de cáncer cerebral de Asia Pacífico en 2020.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el cáncer de cerebro El mercado de diagnóstico en Asia Pacífico son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. y Neusoft Medical Systems.
Razones Comprar informe
- Comprender el panorama del mercado de diagnóstico de cáncer de cerebro de Asia Pacífico e identificar los segmentos del mercado que tienen más probabilidades de garantizar una fuerte retorno
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de diagnóstico de cáncer de cerebro de Asia Pacífico
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en Diagnóstico de cáncer de cerebro de Asia Pacífico mercado identificando segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de diagnóstico de cáncer de cerebro de Asia Pacífico
- Obtener Previsión de ingresos de mercado para el mercado por varios segmentos entre 2021 y 2028 en la región de Asia Pacífico.
Segmentación del mercado de diagnóstico de cáncer cerebral en Asia Pacífico
Por tipo de diagnóstico
- Prueba de imagen
- Resonancia magnética
- Tomografía computarizada
- PET
- Biopsia
- Pruebas moleculares
- Punción lumbar
- Otros
Por tipo de cáncer
< ul>
Por Usuario final
- Hospitales
- Clínicas especializadas
- Centros de Cirugía Ambulatoria
- Otros
Por país
- Asia Pacífico
- China
- Japón
- India
- Corea del Sur
- Australia
- Resto de Asia Pacífico
Empresas mencionadas
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc .
- Koninklijke Philips NV
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 Asia Pacific Brain Cancer Diagnostics Market – By Country
2. Asia Pacific Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Market Opportunities
5.3.1 Increasing Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.5 Impact Analysis
6. Brain Cancer Diagnostics Market – Asia Pacific Analysis
6.1 Asia Pacific Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Asia Pacific: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.3 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.3.2 China: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.3.2.1 China: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.3.3 China: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.3.4 China: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.4 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Japan: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.4.2.1 Japan: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.4.3 Japan: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.4.4 Japan: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.5 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.1 India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.5.2 India: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.5.2.1 India: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.5.3 India: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.5.4 India: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.6 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Australia: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.6.2.1 Australia: Brain Cancer Diagnostics Market, By Imaging Tests, 2019–2028 (USD Million)
10.1.6.3 Australia: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.6.4 Australia: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.7 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.7.2.1 South Korea: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.7.3 South Korea: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.7.4 South Korea: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.8 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type, 2019–2028 (USD Million)
10.1.8.2.1 Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test, 2019–2028 (USD Million)
10.1.8.3 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type, 2019–2028 (USD Million)
10.1.8.4 Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User, 2019–2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Brain Cancer Diagnostics Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. China: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. China: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan: Brain Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. India: Brain Cancer Diagnostics Market, By Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Brain Cancer Diagnostics Market, By Imaging Test– Revenue and Forecast to 2028 (USD Million)
Table 11. India: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. India: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Australia: Brain Cancer Diagnostics Market, By Imaging Tests – Revenue and Forecast to 2028 (USD Million)
Table 15. Australia: Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
Table 16. Australia: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Asia Pacific: Brain Cancer Diagnostics Market, By Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Asia Pacific: Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Organic Developments in the Brain Cancer Diagnostics Market
Table 26. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 27. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Asia Pacific Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - Asia Pacific PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Asia Pacific: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Asia Pacific: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. China: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 30. Japan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. India: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Australia: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. South Korea: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of Asia Pacific: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 36. Growth Strategies Done by the Companies in the Market, (%)- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution